Health Condition 1: null- Rheumatoid arthritis
Conditions
Interventions
Intervention1: DAZZLE CAPSULE: 2 capsule twice a day each of 500 mg after meal with Warm water for three months
Control Intervention1: Nil: Nil
Sponsors
Vasu Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: Presence of any four out of the following seven (Joneâ??s) criteria (according to 1987, revised criteria of American College of Rheumatology) a. Morning stiffness: Stiffness in and around joints lasting one hour before maximal improvement (More than 6 weekâ??s duration). b. Arthritis of three or more joints, at least three joint area, observed by scholar, having pain with soft tissue swelling or joint effusion, not just bony over growth, (more than 6 weeks duration). c. Arthritis of hand joints, at least 1 area in wrist and hand is swollen (more than 6 weeks duration). d. Symmetric arthritis (more than 6 weekâ??s duration). e. Presence of Rheumatoid Nodules f. Serum Rheumatoid factor- positive g. Typical radiographic changes of arthritis on PA view of hand & wrist radiograph that must include erosions or unequivocal bony decalcification, localized in or adjacent to involved joints.
Exclusion criteria
Exclusion criteria: Patients who have developed complications of Rheumatoid Arthritis e.g. severe deformity of joints / bones, pleura-pericardial disease, or else. (2) Patients with poorly controlled Hypertension or with uncontrolled Diabetes Mellitus and having a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months. (4) Patients on prolonged medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study. (5) H/o hypersensitivity to any of the trial drugs or their ingredients. (6) Pregnant/lactating women. (7) Patients having chronicity >10 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the clinical efficacy and safety of Dazzle Capsule in the management of Rheumatoid Arthritis (Amavata)Timepoint: 3months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the symptomatic improvement by Dazzle Capsule in the management of Rheumatoid Arthritis (Amavata)Timepoint: 3months | — |
Countries
India
Contacts
Public ContactShruti Joshi
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar
Outcome results
None listed